Sodium Chloride Injection Recalled

28 de agosto del 2026

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.

Baxter International Inc. announced on Aug. 25, 2026, a voluntary nationwide recall of 0.9% Sodium Chloride Injection 500mL VIAFLEX Plastic Container. The recall was prompted by the potential presence of particulate matter identified as fiberglass in the solution, which may result in serious adverse health consequences, including blood vessel blockage, pulmonary embolism, organ damage, allergic reactions or death. The product is FDA-approved as a source of water and electrolytes and for use as a priming solution in hemodialysis procedures. For more information, see here.

Última actualización: 28 de agosto del 2026